News & Articles

Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed

The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity

Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%

The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

Increase the effectiveness of human vaccines against infectious diseases such as COVID-19

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

The company aims to ramp up its production capacity of more than 50 million antibody tests per month

Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

The cutting-edge technology is utilized to aid drug development and medical equipment production

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Pioneering new class of diagnostic product will transform fight against pandemic

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies

The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff

With medical equipment in short supply, the 3D printing company steps up in coronavirus crisis

Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19